Publication | Open Access
Inhibitory Effects of Quassinoid Derivatives on Epstein-Barr Virus Early Antigen Activation.
16
Citations
0
References
1997
Year
Medicinal ChemistryQuassinoid DerivativesInhibitory EffectsBioassay-guided IsolationMedicineImmunologyAntiviral TherapyAntiviral ResponseTumor PromotersPharmacotherapyAnti-cancer AgentAntitumor PromotersImmunotherapyPharmacologyEster DerivativesViral ImmunityBiomolecular EngineeringDrug Discovery
Short-term in vitro assays for tumor promoters and antitumor promoters (Epstein-Barr virus activation test) were carried out for semisynthetic quassinoids (3-7), which were obtained by esterification of the C-15 OH group of deacetylated isobrucein-B (2). All the ester derivatives showed higher antitumor promoting activity than that of the potent compound 2. A compound containing a fluorinated aliphatic ester showed the highest potency.